BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10469276)

  • 21. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.
    Viereck V; Gründker C; Blaschke S; Frosch KH; Schoppet M; Emons G; Hofbauer LC
    J Cell Biochem; 2005 Dec; 96(6):1244-53. PubMed ID: 16152630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL.
    Bord S; Frith E; Ireland DC; Scott MA; Craig JI; Compston JE
    Bone; 2005 May; 36(5):812-9. PubMed ID: 15794927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis.
    Yano K; Tsuda E; Washida N; Kobayashi F; Goto M; Harada A; Ikeda K; Higashio K; Yamada Y
    J Bone Miner Res; 1999 Apr; 14(4):518-27. PubMed ID: 10234572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-18 up-regulates osteoprotegerin expression in stromal/osteoblastic cells.
    Makiishi-Shimobayashi C; Tsujimura T; Iwasaki T; Yamada N; Sugihara A; Okamura H; Hayashi S; Terada N
    Biochem Biophys Res Commun; 2001 Feb; 281(2):361-6. PubMed ID: 11181055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tumor necrosis factor and lipopolysaccharide affect periodontal ligament cells expressing osteoprotegerin in vitro].
    Li JP; Ling JQ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jul; 38(4):288-91. PubMed ID: 12930661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
    Nyambo R; Cross N; Lippitt J; Holen I; Bryden G; Hamdy FC; Eaton CL
    J Bone Miner Res; 2004 Oct; 19(10):1712-21. PubMed ID: 15355567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SPARC stimulates the synthesis of OPG/OCIF, MMP-2 and DNA in human periodontal ligament cells.
    Fujita T; Shiba H; Sakata M; Uchida Y; Nakamura S; Kurihara H
    J Oral Pathol Med; 2002 Jul; 31(6):345-52. PubMed ID: 12201246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells.
    Brändström H; Jonsson KB; Ohlsson C; Vidal O; Ljunghall S; Ljunggren O
    Biochem Biophys Res Commun; 1998 Jun; 247(2):338-41. PubMed ID: 9642127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2004 Jan; 33(1):46-52. PubMed ID: 14675140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.
    Yasuda H; Shima N; Nakagawa N; Mochizuki SI; Yano K; Fujise N; Sato Y; Goto M; Yamaguchi K; Kuriyama M; Kanno T; Murakami A; Tsuda E; Morinaga T; Higashio K
    Endocrinology; 1998 Mar; 139(3):1329-37. PubMed ID: 9492069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
    Stilgren LS; Rettmer E; Eriksen EF; Hegedüs L; Beck-Nielsen H; Abrahamsen B
    Bone; 2004 Jul; 35(1):256-65. PubMed ID: 15207766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
    Ikeda T; Utsuyama M; Hirokawa K
    J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Osteoclastogenesis Inhibitory Factor (OCIF) /Osteoprotegerin (OPG) as a new therapeutic agent for osteoporosis].
    Mochizuki S; Kiyokawa A; Nagayama Y
    Clin Calcium; 2005 Jan; 15(1):35-42. PubMed ID: 15632471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene.
    Onyia JE; Miles RR; Yang X; Halladay DL; Hale J; Glasebrook A; McClure D; Seno G; Churgay L; Chandrasekhar S; Martin TJ
    J Bone Miner Res; 2000 May; 15(5):863-71. PubMed ID: 10804015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges.
    Makhluf HA; Mueller SM; Mizuno S; Glowacki J
    Biochem Biophys Res Commun; 2000 Feb; 268(3):669-72. PubMed ID: 10679262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin induces osteoprotegerin synthesis via phosphatidylinositol 3'-kinase/mammalian target of rapamycin pathway in human periodontal ligament cells.
    Arayatrakoollikit U; Pavasant P; Yongchaitrakul T
    J Periodontal Res; 2008 Oct; 43(5):537-43. PubMed ID: 18565131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological study on circulating murine osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF): possible role of OPG/OCIF in the prevention of osteoporosis in pregnancy.
    Yano K; Shibata O; Mizuno A; Kobayashi F; Higashio K; Morinaga T; Tsuda E
    Biochem Biophys Res Commun; 2001 Oct; 288(1):217-24. PubMed ID: 11594776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanical force inhibits osteoclastogenic potential of human periodontal ligament fibroblasts through OPG production and ERK-mediated signaling.
    Kook SH; Son YO; Hwang JM; Kim EM; Lee CB; Jeon YM; Kim JG; Lee JC
    J Cell Biochem; 2009 Apr; 106(6):1010-9. PubMed ID: 19206164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor.
    Zannettino AC; Holding CA; Diamond P; Atkins GJ; Kostakis P; Farrugia A; Gamble J; To LB; Findlay DM; Haynes DR
    J Cell Physiol; 2005 Aug; 204(2):714-23. PubMed ID: 15799029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.